An Epstein-Barr virus microRNA blocks interleukin-1 (IL-1) signaling by targeting IL-1 receptor 1

Journal of Virology

Volumn 91, Issue 21, 2017, Pages

  Skinner, Camille M ^a   Ivanov, Nikita S ^a   Barr, Sarah A ^a   Chen, Yan ^a   Skalsky, Rebecca L ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cytokines; Epstein Barr virus; Herpesviruses; Interleukins; microRNA; RNA interference

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA; MICRORNA; MICRORNA BHRF1-2; UNCLASSIFIED DRUG; VIRUS RNA; 3' UNTRANSLATED REGION; BHRF1 PROTEIN, HUMAN HERPESVIRUS 4; INTERLEUKIN 1 RECEPTOR; VIRAL PROTEIN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; CYTOKINE RESPONSE; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LATENT VIRUS INFECTION; LUCIFERASE ASSAY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN TARGETING; VIRUS PATHOGENESIS; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CELL CULTURE; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS LATENCY;

3' UNTRANSLATED REGIONS; B-LYMPHOCYTES; CELLS, CULTURED; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HUMANS; INTERLEUKIN-1BETA; MICRORNAS; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRUS LATENCY;

EID: 85031107226     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00530-17     Document Type: Article

References (73)

1. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. 1998. EBV persistence in memory B cells in vivo. Immunity 9:395-404. https://doi.org/10.1016/S1074-7613(00)80622-6
2. Hislop AD, Taylor GS, Sauce D, Rickinson AB. 2007. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 25:587-617. https://doi.org/10.1146/annurev.immunol.25 .022106.141553
3. Ressing ME, van Gent M, Gram AM, Hooykaas MJ, Piersma SJ, Wiertz EJ. 2015. Immune evasion by Epstein-Barr virus. Curr Top Microbiol Immunol 391:355-381. https://doi.org/10.1007/978-3-319-22834-1_12
4. Vockerodt M, Yap LF, Shannon-Lowe C, Curley H, Wei W, Vrzalikova K, Murray PG. 2015. The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol 235:312-322. https://doi.org/10.1002/path.4459
5. Tsao SW, Tsang CM, To KF, Lo KW. 2015. The role of Epstein-Barr virus in epithelial malignancies. J Pathol 235:323-333. https://doi.org/10.1002/path.4448
6. Horst D, Burrows SR, Gatherer D, van Wilgenburg B, Bell MJ, Boer IG, Ressing ME, Wiertz EJ. 2012. Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation. J Virol 86:572-577. https://doi.org/10.1128/JVI .05151-11
7. van Gent M, Braem SG, de Jong A, Delagic N, Peeters JG, Boer IG, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME. 2014. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with Toll-like receptor signaling. PLoS Pathog 10:e1003960. https://doi.org/10.1371/journal .ppat.1003960
8. Saito S, Murata T, Kanda T, Isomura H, Narita Y, Sugimoto A, Kawashima D, Tsurumi T. 2013. Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication. J Virol 87:4060-4070. https://doi.org/10.1128/JVI.02020-12
9. Salek-Ardakani S, Arrand JR, Mackett M. 2002. Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV. Virology 304: 342-351. https://doi.org/10.1006/viro.2002.1716
10. Croft NP, Shannon-Lowe C, Bell AI, Horst D, Kremmer E, Ressing ME, Wiertz EJ, Middeldorp JM, Rowe M, Rickinson AB, Hislop AD. 2009. Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle. PLoS Pathog 5:e1000490. https://doi.org/10.1371/journal.ppat.1000490
11. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-688. https://doi.org/10.1038/375685a0
12. Mehta A, Baltimore D. 2016. MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol 16:279-294. https://doi.org/10 .1038/nri.2016.40
13. Skalsky RL, Cullen BR. 2015. EBV Noncoding RNAs. Curr Top Microbiol Immunol 391:181-217. https://doi.org/10.1007/978-3-319-22834-1_6
14. Marquitz AR, Raab-Traub N. 2012. The role of miRNAs and EBV BARTs in NPC. Semin Cancer Biol 22:166-172. https://doi.org/10.1016/j.semcancer .2011.12.001
15. Amoroso R, Fitzsimmons L, Thomas WA, Kelly GL, Rowe M, Bell AI. 2011. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation. J Virol 85:996-1010. https://doi.org/10.1128/JVI.01528-10
16. Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B. 2009. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 386:387-397. https://doi.org/10.1016/j.virol .2009.01.006
17. Feederle R, Linnstaedt SD, Bannert H, Lips H, Bencun M, Cullen BR, Delecluse HJ. 2011. A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog 7:e1001294. https://doi.org/10.1371/journal.ppat.1001294
18. Feederle R, Haar J, Bernhardt K, Linnstaedt SD, Bannert H, Lips H, Cullen BR, Delecluse HJ. 2011. The members of a viral miRNA cluster cooperate to transform B lymphocytes. J Virol 85:9801-9810. https://doi.org/10 .1128/JVI.05100-11
19. Seto E, Moosmann A, Gromminger S, Walz N, Grundhoff A, Hammerschmidt W. 2010. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 6:e1001063. https://doi.org/10.1371/journal.ppat.1001063
20. Wahl ALS, Esoda C, Krisko JF, Martinez-Torres F, Delecluse HJ, Cullen BR, Garcia JV. 2013. A cluster of virus-encoded microRNAs accelerates acute systemic Epstein-Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivo. J Virol 87:5437-5446. https://doi.org/10.1128/JVI.00281-13
21. Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, Moosmann A, Hammerschmidt W. 2016. Epstein-Barr virus microRNAs reduce immune surveillance by virusspecific CD8+ T cells. Proc Natl Acad Sci U S A 113:E6467-E6475. https://doi.org/10.1073/pnas.1605884113
22. Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, Zielinski C, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Hammerschmidt W. 2016. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med 213:2065-2080. https://doi.org/10.1084/jem.20160248
23. Xia T, O'Hara A, Araujo I, Barreto J, Carvalho E, Sapucaia JB, Ramos JC, Luz E, Pedroso C, Manrique M, Toomey NL, Brites C, Dittmer DP, Harrington WJ, Jr. 2008. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68:1436-1442. https://doi.org/10.1158/0008-5472.CAN-07-5126
24. Haneklaus M, Gerlic M, Kurowska-Stolarska M, Rainey AA, Pich D, McInnes IB, Hammerschmidt W, O'Neill LA, Masters SL. 2012. Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production. J Immunol 189:3795-3799. https://doi.org/10 .4049/jimmunol.1200312
25. Ambrosio MR, Navari M, Di Lisio L, Leon EA, Onnis A, Gazaneo S, Mundo L, Ulivieri C, Gomez G, Lazzi S, Piris MA, Leoncini L, De Falco G. 2014. The Epstein-Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infect Agents Cancer 9:12. https://doi.org/10.1186/1750-9378-9-12
26. Huang WT, Lin CW. 2014. EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-γ/STAT1 pathway associated with disease progression in nasal NK-cell lymphoma. Am J Pathol 184:1185-1197. https://doi.org/10 .1016/j.ajpath.2013.12.024
27. Lin TC, Liu TY, Hsu SM, Lin CW. 2013. Epstein-Barr virus-encoded miRBART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK/T-cell lymphoma. Am J Pathol 182:1865-1875. https://doi.org/10.1016/j.ajpath.2013.01.025
28. Dolken L, Malterer G, Erhard F, Kothe S, Friedel CC, Suffert G, Marcinowski L, Motsch N, Barth S, Beitzinger M, Lieber D, Bailer SM, Hoffmann R, Ruzsics Z, Kremmer E, Pfeffer S, Zimmer R, Koszinowski UH, Grasser F, Meister G, Haas J. 2010. Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gammaherpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7:324-334. https://doi.org/10.1016/j.chom.2010.03.008
29. Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M, Nusbaum JD, Feederle R, Delecluse HJ, Luftig MA, Tuschl T, Ohler U, Cullen BR. 2012. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog 8:e1002484. https://doi.org/10.1371/journal.ppat.1002484
30. Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, Shamulailatpam P, Love CL, Dave SS, Tuschl T, Ohler U, Cullen BR. 2011. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10:515-526. https://doi.org/10.1016/j.chom.2011.09.012
31. Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA. 2012. EBV and human microRNAs cotarget oncogenic and apoptotic viral and human genes during latency. EMBO J 31:2207-2221. https://doi.org/10 .1038/emboj.2012.63
32. Abend JR, Ramalingam D, Kieffer-Kwon P, Uldrick TS, Yarchoan R, Ziegelbauer JM. 2012. KSHV microRNAs target two components of the TLR/IL-1R signaling cascade, IRAK1 and MYD88, to reduce inflammatory cytokine expression. J Virol 86:11663-11674. https://doi.org/10.1128/JVI .01147-12
33. Moody R, Zhu Y, Huang Y, Cui X, Jones T, Bedolla R, Lei X, Bai Z, Gao SJ. 2013. KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. PLoS Pathog 9:e1003857. https://doi.org/10.1371/journal.ppat.1003857
34. Skalsky RL, Barr SA, Jeffery AJ, Blair T, Estep R, Wong SW. 2016. Japanese macaque rhadinovirus encodes a viral microRNA mimic of the miR-17 family. J Virol 90:9350-9363. https://doi.org/10.1128/JVI.01123-16
35. Lei X, Bai Z, Ye F, Xie J, Kim CG, Huang Y, Gao SJ. 2010. Regulation of NF-κinhibitor IκBα and viral replication by a KSHV microRNA. Nat Cell Biol 12:193-199. https://doi.org/10.1038/ncb2019
36. Landais I, Pelton C, Streblow D, DeFilippis V, McWeeney S, Nelson JA. 2015. Human cytomegalovirus miR-UL112-3p targets TLR2 and modulates the TLR2/IRAK1/NFκB signaling pathway. PLoS Pathog 11: e1004881. https://doi.org/10.1371/journal.ppat.1004881
37. Weber A, Wasiliew P, Kracht M. 2010. Interleukin-1 (IL-1) pathway. Sci Signal 3:cm1. https://doi.org/10.1126/scisignal.3105cm1
38. Skalsky RL, Kang D, Linnstaedt SD, Cullen BR. 2014. Evolutionary conservation of primate lymphocryptovirus microRNA targets. J Virol 88: 1617-1635. https://doi.org/10.1128/JVI.02071-13
39. Gewurz BE, Towfic F, Mar JC, Shinners NP, Takasaki K, Zhao B, Cahir-McFarland ED, Quackenbush J, Xavier RJ, Kieff E. 2012. Genome-wide siRNA screen for mediators of NF-κB activation. Proc Natl Acad Sci U S A 109:2467-2472. https://doi.org/10.1073/pnas.1120542109
40. Majoros WH, Lekprasert P, Mukherjee N, Skalsky RL, Corcoran DL, Cullen BR, Ohler U. 2013. MicroRNA target site identification by integrating sequence and binding information. Nat Methods 10:630-633. https://doi.org/10.1038/nmeth.2489
41. Haar J, Contrant M, Bernhardt K, Feederle R, Diederichs S, Pfeffer S, Delecluse HJ. 2016. The expression of a viral microRNA is regulated by clustering to allow optimal B cell transformation. Nucleic Acids Res 44:1326-1341. https://doi.org/10.1093/nar/gkv1330
42. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233. https://doi.org/10.1016/j.cell.2009.01.002
43. Pages F, Galon J, Karaschuk G, Dudziak D, Camus M, Lazar V, Camilleri-Broet S, Lagorce-Pages C, Lebel-Binay S, Laux G, Fridman WH, Henglein B. 2005. Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells. Blood 105:1632-1639. https://doi.org/10 .1182/blood-2004-08-3196
44. Ansari MA, Singh VV, Dutta S, Veettil MV, Dutta D, Chikoti L, Lu J, Everly D, Chandran B. 2013. Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells. J Virol 87:8606-8623. https://doi.org/10.1128/JVI .00805-13
45. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. 2004. Fast and effective prediction of microRNA/target duplexes. RNA 10:1507-1517. https://doi.org/10.1261/rna.5248604
46. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. 2010. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 84:11670-11678. https://doi.org/10 .1128/JVI.01248-10
47. Gottwein E, Cullen BR. 2010. A human herpesvirus microRNA inhibits p21 expression and attenuates p21-mediated cell cycle arrest. J Virol 84:5229-5237. https://doi.org/10.1128/JVI.00202-10
48. Winzen R, Gowrishankar G, Bollig F, Redich N, Resch K, Holtmann H. 2004. Distinct domains of AU-rich elements exert different functions in mRNA destabilization and stabilization by p38 mitogen-activated protein kinase or HuR. Mol Cell Biol 24:4835-4847. https://doi.org/10.1128/MCB.24.11.4835-4847.2004
49. Dinarello CA. 2005. The many worlds of reducing interleukin-1. Arthritis Rheum 52:1960-1967. https://doi.org/10.1002/art.21107
50. Dinarello CA. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-550. https://doi.org/10 .1146/annurev.immunol.021908.132612
51. Palomo J, Dietrich D, Martin P, Palmer G, Gabay C. 2015. The interleukin (IL)-1 cytokine family: balance between agonists and antagonists in inflammatory diseases. Cytokine 76:25-37. https://doi.org/10.1016/j.cyto .2015.06.017
52. Rosser EC, Mauri C. 2015. Regulatory B cells: origin, phenotype, and function. Immunity 42:607-612. https://doi.org/10.1016/j.immuni.2015 .04.005
53. Krelin Y, Voronov E, Dotan S, Elkabets M, Reich E, Fogel M, Huszar M, Iwakura Y, Segal S, Dinarello CA, Apte RN. 2007. Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res 67:1062-1071. https://doi.org/10.1158/0008-5472.CAN-06-2956
54. Man SM, Kanneganti TD. 2015. Regulation of inflammasome activation. Immunol Rev 265:6-21. https://doi.org/10.1111/imr.12296
55. van de Veerdonk FL, Netea MG, Dinarello CA, Joosten LA. 2011. Inflammasome activation and IL-1β and IL-18 processing during infection. Trends Immunol 32:110-116. https://doi.org/10.1016/j.it.2011.01.003
56. Xiang Y, Moss B. 1999. IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc Natl Acad Sci U S A 96:11537-11542. https://doi.org/10.1073/pnas.96.20.11537
57. O'Neill LA, Sheedy FJ, McCoy CE. 2011. MicroRNAs: the fine-tuners of Toll-like receptor signaling. Nat Rev Immunol 11:163-175. https://doi .org/10.1038/nri2957
58. Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC, Flemington EK. 2008. Epstein-Barr virus latent membrane protein 1 induces cellular microRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol 82:1946-1958. https://doi .org/10.1128/JVI.02136-07
59. Yin Q, McBride J, Fewell C, Lacey M, Wang X, Lin Z, Cameron J, Flemington EK. 2008. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol 82:5295-5306. https://doi.org/10.1128/JVI.02380-07
60. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, Kohlhaas S, Das PP, Miska EA, Rodriguez A, Bradley A, Smith KG, Rada C, Enright AJ, Toellner KM, Maclennan IC, Turner M. 2007. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27:847-859. https://doi.org/10.1016/j.immuni.2007.10.009
61. Weber A, Wasiliew P, Kracht M. 2010. Interleukin-1beta (IL-1beta) processing pathway. Sci Signal 3:cm2. https://doi.org/10.1126/scisignal .3105cm2
62. Niebler M, Qian X, Hofler D, Kogosov V, Kaewprag J, Kaufmann AM, Ly R, Bohmer G, Zawatzky R, Rosl F, Rincon-Orozco B. 2013. Posttranslational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53. PLoS Pathog 9:e1003536. https://doi .org/10.1371/journal.ppat.1003536
63. Taxman DJ, Huang MT, Ting JP. 2010. Inflammasome inhibition as a pathogenic stealth mechanism. Cell Host Microbe 8:7-11. https://doi .org/10.1016/j.chom.2010.06.005
64. Gyrd-Hansen M, Meier P. 2010. IAPs: from caspase inhibitors to modulators of NF-κB, inflammation, and cancer. Nat Rev Cancer 10:561-574. https://doi.org/10.1038/nrc2889
65. Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessinger J, Wigler MH, Bar-Sagi D. 1993. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260:1338-1343. https://doi.org/10.1126/science.8493579
66. Deshpande P, Cavanagh MM, Le Saux S, Singh K, Weyand CM, Goronzy JJ. 2013. IL-7-and IL-15-mediated TCR sensitization enables T cell responses to self-antigens. J Immunol 190:1416-1423. https://doi.org/10 .4049/jimmunol.1201620
67. Wang Q, Downey GP, Herrera-Abreu MT, Kapus A, McCulloch CA. 2005. SHP-2 modulates interleukin-1-induced Ca2+ flux and ERK activation via phosphorylation of phospholipase Cγ1. J Biol Chem 280:8397-8406. https://doi.org/10.1074/jbc.M410462200
68. Kang D, Skalsky RL, Cullen BR. 2015. EBV BART microRNAs target multiple proapoptotic cellular genes to promote epithelial cell survival. PLoS Pathog 11:e1004979. https://doi.org/10.1371/journal.ppat.1004979
69. Xia Y, Chu W, Qi Q, Xun L. 2015. New insights into the QuikChange process guide the use of Phusion DNA polymerase for site-directed mutagenesis. Nucleic Acids Res 43:e12. https://doi.org/10.1093/nar/gku1189
70. Fellmann C, Hoffmann T, Sridhar V, Hopfgartner B, Muhar M, Roth M, Lai DY, Barbosa IA, Kwon JS, Guan Y, Sinha N, Zuber J. 2013. An optimized microRNA backbone for effective single-copy RNAi. Cell Rep 5:1704-1713. https://doi.org/10.1016/j.celrep.2013.11.020
71. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25. https://doi.org/10.1186/gb-2009-10-3-r25
72. Li B, Ruotti V, Stewart RM, Thomson JA, Dewey CN. 2010. RNA-Seq gene expression estimation with read mapping uncertainty. Bioinformatics 26:493-500. https://doi.org/10.1093/bioinformatics/btp692
73. Corcoran DL, Georgiev S, Mukherjee N, Gottwein E, Skalsky RL, Keene JD, Ohler U. 2011. PARalyzer: definition of RNA binding sites from PAR-CLIP short-read sequence data. Genome Biol 12:R79. https://doi.org/10.1186/gb-2011-12-8-r79